Lara Zafrani
- Nephrology top 1%
- Acute Kidney Injury Research 9
- Renal Diseases and Glomerulopathies 8
- Infectious Diseases top 2%
- COVID-19 Clinical Research Studies 9
- Transplantation top 5%
- Neurology top 2%
- Long-Term Effects of COVID-19 7
-
- Sepsis Diagnosis and Treatment 17
- Pneumocystis jirovecii pneumonia detection and treatment 9
-
- Neutropenia and Cancer Infections 15
-
- Complement system in diseases 14
- Co-authors
- Élie AzoulayMichaël DarmonStéphanie PonsSofiane FodilThibault DupontGuillaume DumasCan İncePaul Gabarre
- Journals
- SHILAP Revista de lepidopterología (1 paper)The Journal of Immunology (1 paper)PLoS ONE (4 papers)
- Partner nations
- FranceUnited StatesNetherlands
In The Last Decade
Lara Zafrani
103 papers receiving 2.8k citations
Hit Papers
Peers
Comparison fields: 5 of 115
- Nephrology 499
- Critical Care and Intensive Care Medicine 316
- Infectious Diseases 901
- Transplantation 105
- Neurology 446
Countries citing papers authored by Lara Zafrani
This map shows the geographic impact of Lara Zafrani's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lara Zafrani with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lara Zafrani more than expected).
Fields of papers citing papers by Lara Zafrani
This network shows the impact of papers produced by Lara Zafrani. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lara Zafrani. The network helps show where Lara Zafrani may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Lara Zafrani, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 0 | |
| 3 | 2024 | 2 | |
| 4 | 2023 | 0 | |
| 5 | 2022 | 2 | |
| 6 | 2022 | 15 | |
| 7 | 2022 | 4 | |
| 8 | 2022 | 4 | |
| 9 | 2021 | 2 | |
| 10 | 2021 | 8 | |
| 11 | 2020 | 153 | |
| 12 | 2020 | 18 | |
| 13 | 2018 | 18 | |
| 14 | 2017 | 3 | |
| 15 | 2015 | 76 | |
| 16 | 2015 | 17 | |
| 17 | 2014 | 50 | |
| 18 | 2013 | 98 | |
| 19 | 2012 | 49 | |
| 20 | 2007 | 15 |
About Lara Zafrani
Lara Zafrani is a scholar working on Nephrology, Transplantation and Critical Care and Intensive Care Medicine, having authored 109 papers that have together received 2.8k indexed citations. Recurring topics across this work include Sepsis Diagnosis and Treatment (17 papers), Neutropenia and Cancer Infections (15 papers), Complement system in diseases (14 papers), Acute Kidney Injury Research (9 papers), Pneumocystis jirovecii pneumonia detection and treatment (9 papers), COVID-19 Clinical Research Studies (9 papers), Renal Diseases and Glomerulopathies (8 papers) and Long-Term Effects of COVID-19 (7 papers). The work is most often cited by research in Nephrology (499 citations), Critical Care and Intensive Care Medicine (316 citations) and Infectious Diseases (901 citations). Lara Zafrani has collaborated with scholars based in France, United States and Netherlands. Frequent co-authors include Élie Azoulay, Michaël Darmon, Stéphanie Pons, Sofiane Fodil, Thibault Dupont, Guillaume Dumas, Can İnce, Paul Gabarre, Emmanuel Canet and Virginie Lemiale. Their work appears in journals such as SHILAP Revista de lepidopterología, The Journal of Immunology and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.